openPR Logo
Press release

Codex Labs Introduces First Bia OTC: Eczema Relief Lotion

02-25-2025 02:02 PM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Codex Labs

Codex Labs

SAN JOSE, CA - Feb 25th, 2025 - Codex Labs (https://www.codexlabscorp.com/), a Silicon Valley skintech company, has launched the first of its Bia over-the-counter (OTC) topicals for eczema management. Bia, meaning "food" in Gaelic, is often paired with "nourishment" in Celtic philosophy.

The BIA eczema lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses hydration, skin barrier repair (both increased ceramide and structural protein production), and itch reduction in distinct yet synergistically-effective ways.

"At Codex Labs, we are excited to expand the clinical effectiveness of our plant-biotech-based skincare solutions to addressing itch and dryness symptoms associated with atopic dermatitis, or eczema," stated Dr. Barbara Paldus, CEO and Founder of Codex Labs. "By doing so, we have further demonstrated our commitment to bringing much-needed relief to people suffering from inflammation-based skin conditions."

The OTC Eczema Relief Lotion was designed to be used in conjunction with the Bia Unscented Soap, the first vegan, MyMicrobiome-certified soap launched in 2021. The combination, called "Eczema Essentials," delivers skin hydration, moisture retention, skin barrier repair, and relief from itching.

"The Eczema Essentials set was tested in a clinical study and performed well for managing mild to moderate eczema. It is remarkable to think that these are over-the-counter products, available to everyone without a prescription," stated Dr. Peter Lio, a leading US expert in pediatric eczema and Codex Labs Medical Advisory Board member.

The Eczema Essentials set was also combined with the Antu Skin Barrier Support supplement in a trio called "Ditch the Itch." The addition of the Antu supplement provides l-histidine, an amino acid used by the body for filaggrin protein and natural moisturizing factor production, as well as a novel antioxidant from Patagonia (M3 Trademark ) that helps address internal inflammation by combatting free radicals production and lipid peroxidation.

This topical-ingestible "Ditch the Itch" trio underwent a clinical trial on subjects having mild to moderate eczema (SCORAD = 34.5). The measured improvement in 8 weeks included:

*
93% reduction in eczema score (SCORAD) in 100% of subjects

*
88% reduction of itch in 97% of subjects

*
117% hydration increase in 91% of subjects

*
83% flakiness (desquamation) decrease in 97% of subjects

*
29% trans-epidermal water loss (TEWL) reduction in 79% of subjects

The clinical results of this combined inside-out approach demonstrate the importance of addressing skin conditions with both topicals and ingestibles in an integrative skin-gut approach.

All three products are vegan- and cruelty-free, and the two topicals are also MyMicrobiome-certified. All Codex products are manufactured in high-tech GMP (Good Manufacturing Practice) facilities to ensure they are made to the highest quality standards. They contain sustainably optimized ingredients and are filled in renewable, sugarcane green PE tubes, which reduces their carbon footprint by over 50%.

About Codex Labs

Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Our products are focused on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema, and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free, and sustainable dermaceutical solutions.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=codex-labs-introduces-first-bia-otc-eczema-relief-lotion]
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Codex Labs Introduces First Bia OTC: Eczema Relief Lotion here

News-ID: 3885988 • Views:

More Releases from ABNewswire

Metastatic Pancreatic Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential
Metastatic Pancreatic Cancer Pipeline Outlook 2025: Insights Into Therapies, Res …
DelveInsight's, "Metastatic Pancreatic Cancer Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It covers the Metastatic Pancreatic Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Metastatic Pancreatic Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Metastatic Pancreatic Cancer pipeline products in this
Pancreatic Ductal Adenocarcinoma Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential
Pancreatic Ductal Adenocarcinoma Pipeline Outlook 2025: Insights Into Therapies, …
DelveInsight's, "Pancreatic Ductal Adenocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It covers the Pancreatic Ductal Adenocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pancreatic Ductal Adenocarcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the
Advanced Recurrent Ovarian Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential
Advanced Recurrent Ovarian Cancer Pipeline Outlook 2025: Insights Into Therapies …
DelveInsight's, "Advanced Recurrent Ovarian Cancer Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Advanced Recurrent Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates in the
HER2 Positive Gastric Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential
HER2 Positive Gastric Cancer Pipeline Outlook 2025: Insights Into Therapies, Res …
DelveInsight's, "HER2 Positive Gastric Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HER2 Positive Gastric Cancer pipeline landscape. It covers the HER2 Positive Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2 Positive Gastric Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products

All 5 Releases


More Releases for Codex

Codex Labs to Exhibit at 2025 American Association of Naturopathic Physicians An …
Indian Wells, Calif. - July 8th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the American Association of Naturopathic Physicians (AANP) Annual Convention [https://naturopathic.org/page/AANP2025]. From July 10th to 12th, naturopathic professionals will gather in Palm Springs at the Renaissance Esmeralda Resort, Indian Wells to explore the latest knowledge on a wide range of topics, including dietary interventions and supplements, women's
Codex Labs to Exhibit at 2025 ASN Annual Meeting, Showcase Innovative Microbiome …
Orlando, Fla. - May 23rd, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the American Society for Nutrition (ASN) NUTRITION 2025 [https://nutrition.org/meeting/] event. From May 31st through June 3rd, the world's top researchers, clinicians, public health professionals, policy makers, and industry leaders will gather at the Orange County Convention Center to advance nutrition science and its practical application. NUTRITION 2025 will
Codex Labs Showcased Innovative Microbiome-Friendly Skincare at 2025 AAD Annual …
Orlando, Fla. - March 24th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech company that offers Skin-Gut-Brain-Biome Supplements & Skincare, participated in the 2025 American Academy of Dermatology (AAD) Annual Meeting [https://www.aad.org/member/meetings-education/am25]. The world's top dermatologists, researchers, and skincare industry experts gathered for the flagship event in dermatology on March 7-11 at the Orange County Convention Center to share groundbreaking discoveries in skin health. Codex Labs was founded by Dr. Barbara Paldus,
Codex Labs to Exhibit at 2025 AAD Annual Meeting, Showcase Innovative Microbiome …
Orlando, Fla. - March 4th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in the 2025 American Academy of Dermatology (AAD) Annual Meeting [https://www.aad.org/member/meetings-education/am25]. The world's top dermatologists, researchers, and skincare industry experts will gather for the flagship event in dermatology from March 7-11, 2025, at the Orange County Convention Center to share groundbreaking discoveries in skin health. Codex Labs is a
Pesticide Residue Testing Market To See Huge Growth, Industry Research Technolog …
The "Pesticide Residue Testing Market" report provides exhaustive information on the different business characteristics of the industry such as approaches, models and key players working in different regions. Responsible for providing accurate and important information related to market conditions and developments, and to estimate growth factors, quantitative analysis and business processes. This report constitutes the market growth, market characteristics, and market size of the Pesticide Residue Testing industry and categorizes
Codex Mysterium unique & eccentric puzzle book now live on Kickstarter
Innovario is excited to announce the launch of a Kickstarter campaign for Codex Mysterium; an immersive and richly illustrated puzzle book, filled with a diverse mix of unique and interrelated brain teasers, riddles and conundrums. It features many one-of-a-kind puzzles designed specifically for this book as well as unconventional twists on well-known puzzle types. Codex Mysterium is a stand-alone sequel to the successful Codex Engimatum puzzle book. Rami Hansenne, the author,